UAB Alzheimer's Disease Center Core Cohort - Imaging Substudy

PHASE2RecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

April 20, 2018

Primary Completion Date

April 1, 2026

Study Completion Date

April 1, 2026

Conditions
Alzheimer Disease
Interventions
DRUG

[C-11]PiB-PET/MRI

All study participants will undergo brain imaging with \[C-11\]PiB-PET/MRI. \[C-11\]PiB is a PET imaging agent used primarily to measure the amount of abnormal protein (called beta-amyloid) in the brain. The investigator will also use this tracer to evaluate regional cerebral blood flow.

Trial Locations (1)

35294

RECRUITING

University of Alabama at Birmingham Medical Center, Birmingham

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

University of Alabama at Birmingham

OTHER